CGEM FY 2025 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$894M

FY 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$242M

Net Income

-$220M

EPS (Diluted)

$0.00

Cash Flow

Operating Cash Flow

-$176M

Free Cash Flow

-$176M

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$448M

Total Liabilities

$40M

Stockholders' Equity

$409M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$306,000	+100.0%
Operating Income	-$242M	-$197M	-22.7%
Net Income	-$220M	-$167M	-31.4%